FEBNM
Certificate of Fellowship of the European Board of Nuclear Medicine
Treatment ComplicationsEnglish
Exam overviewPractice session
After first-cycle peptide receptor radionuclide therapy, a patient develops persistent nausea, abdominal pain, hypotension, flushing, and wheeze several hours after treatment. What complication should be considered first?
Loading your practice session…